World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
80
Citations
22627
World Ranking
1632
National Ranking
813

Keith R. Jerome publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Keith R. Jerome sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 429 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Keith R. Jerome D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Keith R. Jerome sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • Gene
  • Internal medicine

Immunology, Virology, Viral load, Virus and Hematopoietic stem cell transplantation are his primary areas of study. His studies deal with areas such as Mortality rate, Internal medicine, Liter and Confidence interval as well as Immunology. Keith R. Jerome works on Virology which deals in particular with Herpes simplex virus.

His Viral load study combines topics from a wide range of disciplines, such as Haematopoiesis, Hematopoietic stem cell, Immune system, Genetic enhancement and Transplantation. His research integrates issues of Area under the curve, Respiratory tract infections, Stem cell and Serology in his study of Virus. His biological study spans a wide range of topics, including Respiratory disease, Bronchoalveolar lavage, Cytopenia and Orthomyxoviridae.

His most cited work include:

  • Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California. (124 citations)
  • Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California. (124 citations)
  • Hematopoietic-stem-cell-based gene therapy for HIV disease. (110 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Virology, Immunology, Internal medicine, Viral load and Severe acute respiratory syndrome coronavirus 2. His work in Virology covers topics such as Real-time polymerase chain reaction which are related to areas like Molecular biology. His work in Immunology covers topics such as Hematopoietic stem cell transplantation which are related to areas like Bronchoalveolar lavage.

His Viral load research integrates issues from Congenital cytomegalovirus infection, Ganciclovir and Viremia. His Severe acute respiratory syndrome coronavirus 2 study integrates concerns from other disciplines, such as Pandemic and Coronavirus. Keith R. Jerome interconnects HSL and HSV and Gene in the investigation of issues within Herpes simplex virus.

He most often published in these fields:

  • Virology (64.86%)
  • Immunology (39.28%)
  • Internal medicine (33.33%)

What were the highlights of his more recent work (between 2019-2021)?

  • Severe acute respiratory syndrome coronavirus 2 (26.36%)
  • Virology (64.86%)
  • Internal medicine (33.33%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Severe acute respiratory syndrome coronavirus 2, Virology, Internal medicine, Viral load and Pandemic. Severe acute respiratory syndrome coronavirus 2 is closely attributed to Coronavirus in his work. His Virology research is multidisciplinary, relying on both Real-time polymerase chain reaction and Digital polymerase chain reaction.

The study of Internal medicine is intertwined with the study of Gastroenterology in a number of ways. His Viral load study necessitates a more in-depth grasp of Immunology. The study incorporates disciplines such as Genome editing, CRISPR, Clade and Sequence in addition to Virus.

Between 2019 and 2021, his most popular works were:

  • Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California. (124 citations)
  • Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California. (124 citations)
  • Point-of-care testing for COVID-19 using SHERLOCK diagnostics (98 citations)

In his most recent research, the most cited papers focused on:

  • Virus
  • Gene
  • Internal medicine

His primary scientific interests are in Severe acute respiratory syndrome coronavirus 2, Pandemic, 2019-20 coronavirus outbreak, Virology and Coronavirus. His 2019-20 coronavirus outbreak study combines topics in areas such as Sample, RNA, Viral genetics, Reproducibility and Phosphate buffered saline. His Virology research is multidisciplinary, incorporating perspectives in Real-time polymerase chain reaction and Sequence analysis.

His work carried out in the field of Real-time polymerase chain reaction brings together such families of science as Quantitative Reverse Transcriptase PCR, Respiratory infection, Polymerase chain reaction and Healthcare system. His Coronavirus study frequently links to adjacent areas such as Contact tracing. His Outbreak research includes themes of Test, Disease and Public health.

Best Publications

  • Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing.

    Julia Joung;Alim Ladha;Makoto Saito;Nam Gyun Kim

  • Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.

    Andrew Bryan;Gregory Pepper;Mark H. Wener;Susan L. Fink

  • Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate.

    Amin Addetia;Katharine H.D. Crawford;Katharine H.D. Crawford;Adam Dingens;Haiying Zhu

  • Immune surveillance in multiple sclerosis patients treated with natalizumab

    Olaf Stüve;Olaf Stüve;Christina M Marra;Keith R Jerome;Keith R Jerome;Keith R Jerome;Linda Cook;Linda Cook;Linda Cook

  • Comparative Performance of SARS-CoV-2 Detection Assays Using Seven Different Primer-Probe Sets and One Assay Kit.

    Arun K. Nalla;Amanda M. Casto;Amanda M. Casto;Meei Li W. Huang;Garrett A. Perchetti

  • Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study

    Margaret L Green;Margaret L Green;Wendy Leisenring;Wendy Leisenring;Hu Xie;T Christopher Mast

  • Point-of-care testing for COVID-19 using SHERLOCK diagnostics

    Julia Joung;Alim Ladha;Makoto Saito;Michael Segel

  • MUC-1 Epithelial Tumor Mucin-Based Immunity and Cancer Vaccines

    Olivera J. Finn;Keith R. Jerome;Robert A. Henderson;Gabriele Pecher

  • Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States.

    Joseph R. Fauver;Mary E. Petrone;Emma B. Hodcroft;Emma B. Hodcroft;Kayoko Shioda

  • Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.

    Olaf Stüve;Christina M. Marra;Amit Bar-Or;Masaaki Niino

  • Cryptic transmission of SARS-CoV-2 in Washington state.

    Trevor Bedford;Trevor Bedford;Alexander L. Greninger;Alexander L. Greninger;Pavitra Roychoudhury;Pavitra Roychoudhury;Lea M. Starita

  • Herpes Simplex Virus Inhibits Apoptosis through the Action of Two Genes, Us5 and Us3

    Keith R. Jerome;Keith R. Jerome;Richard Fox;Zheng Chen;Amy E. Sears

  • Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides.

    C G Ioannides;B Fisk;K R Jerome;T Irimura

  • Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California.

    Xianding Deng;Wei Gu;Scot Federman;Louis du Plessis

  • In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age.

    Nicole A.P. Lieberman;Vikas Peddu;Hong Xie;Lasata Shrestha

  • Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories.

    Joshua A. Lieberman;Gregory Pepper;Samia N. Naccache;Meei Li Huang;Meei Li Huang

  • Quantitation of BK Virus Load in Serum for the Diagnosis of BK Virus–Associated Nephropathy in Renal Transplant Recipients

    Ajit P. Limaye;Keith R. Jerome;Christian S. Kuhr;James Ferrenberg

  • High-Throughput Quantitative Analysis of Hepatitis B Virus DNA in Serum Using the TaqMan Fluorogenic Detection System

    Keith R. Loeb;Keith R. Jerome;James Goddard;Meei-li Huang

  • Treatment of refractory BK virus-associated nephropathy with cidofovir.

    Pradeep V. Kadambi;Michelle A. Josephson;James Williams;Lawrence Corey

  • Quantitative Stability of DNA after Extended Storage of Clinical Specimens as Determined by Real-Time PCR

    Keith R. Jerome;Meei Li Huang;Anna Wald;Stacy Selke

  • Cryptic transmission of SARS-CoV-2 in Washington State.

    Trevor Bedford;Trevor Bedford;Alexander L Greninger;Alexander L Greninger;Pavitra Roychoudhury;Pavitra Roychoudhury;Lea M Starita

  • Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate

    Amin Addetia;Katharine Hd Crawford;Adam Dingens;Haiying Zhu

Frequent Co-Authors

Alexander L. Greninger
Alexander L. Greninger University of Washington
Michael Boeckh
Michael Boeckh Fred Hutchinson Cancer Research Center
Janet A. Englund
Janet A. Englund Seattle Children's Hospital
Wendy Leisenring
Wendy Leisenring Fred Hutchinson Cancer Research Center
Jane Kuypers
Jane Kuypers University of Washington
Joshua T. Schiffer
Joshua T. Schiffer Fred Hutchinson Cancer Research Center
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
Anna Wald
Anna Wald University of Washington
Amalia Magaret
Amalia Magaret University of Washington
Hans Peter Kiem
Hans Peter Kiem Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Immunology in the USA, exploring related healthcare degrees can broaden career opportunities. Many Immunology graduates pursue nursing paths due to the demand for professionals with strong biological and clinical knowledge.

Accelerated programs are popular for those who want to shift careers quickly. The accelerated FNP programs offer a fast track to becoming a Family Nurse Practitioner, blending immunological expertise with advanced patient care skills.

If you’re new to nursing, consider online options like the best online RN programs for non nurses. These programs are designed to guide individuals without prior nursing education into Registered Nurse roles efficiently.

For quicker entry points, programs like absn programs with high acceptance rates enable students to obtain a Bachelor of Science in Nursing rapidly and with less stringent admission requirements.

Similarly, lpn programs easy to get into offer practical pathways into nursing as Licensed Practical Nurses, providing valuable hands-on experience in healthcare settings.

By combining immunology background with these nursing degrees, graduates can enhance their qualifications and access diverse career pathways in research, clinical practice, and healthcare leadership.

Best Scientists Citing Keith R. Jerome

Trending Scientists

Recently Published Articles